Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02169674Phase 4Completed
A Phase 4 trial of hepatitis B vaccine recombinant in hepatitis B (HBV), sponsored by University of British Columbia. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02169674.